Budesonide

Generic name: Pronounced as (bue des' oh nide)
Brand names
  • Entocort® EC
  • Tarpeyo ®
Click on drug name to hear pronunciation

Medical Content Reviewed By HelloPharmacist Staff

Last Revised - 02/15/2022

Budesonide (Entocort EC) is used to treat Crohn's disease (a condition in which the body attacks the lining of the digestive tract, causing pain, diarrhea, weight loss, and fever). Budesonide (Tarpeyo) is used to decrease protein in the urine in patients with primary immunoglobulin A nephropathy (kidney disease that occurs in some people when too much immunoglobin A builds up in the kidney, causing inflammation). Budesonide is in a class of medications called corticosteroids. It works by decreasing inflammation (swelling) in the digestive tract of people who have Crohn's disease or in the kidney of people with nephropathy.

Budesonide comes as a capsule to take by mouth. It is usually taken once a day in the morning. Take budesonide at around the same time every day. Budesonide (Tarpeyo) should be taken at least one hour before a meal. Your doctor will tell you how long to take budesonide. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take budesonide exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.

Swallow the capsules whole; do not split, chew, or crush them. If you are unable to swallow the budesonide (Entocort EC) capsules whole, the capsules may be opened and sprinkled on a tablespoonful of apple sauce, mixed well and swallowed whole with no chewing within 30 minutes of mixing. The applesauce mixture should be followed by a full glass of water.

Budesonide may help control your symptoms, but it will not cure your condition. Your doctor will watch you carefully to see how well budesonide works for you. If your symptoms are controlled, your doctor may decrease your dose of budesonide. After your symptoms have been controlled for 3 months, your doctor may slowly decrease your dose and then stop treating you with this medication. It is important to tell your doctor how you are feeling during your treatment.

Ask your pharmacist or doctor for a copy of the manufacturer's information for the patient.

This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.

Before taking budesonide,

  • tell your doctor and pharmacist if you are allergic to budesonide, or any other medications.

  • tell your doctor and pharmacist what other prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Be sure to mention any of the following: cyclosporine, erythromycin, ketoconazole, indinavir, itraconazole, ritonavir, and saquinavir. Your doctor may need to change the doses of your medications or monitor you carefully for side effects. Many other medications may also interact with budesonide, so be sure to tell your doctor about all the medications you are taking, even those that do not appear on this list.

  • tell your doctor if you or anyone in your family has had diabetes (high blood sugar) or glaucoma, or if you have tuberculosis, high blood pressure, osteoporosis (a condition in which the bones become thin and weak and break easily), stomach ulcer, cataracts, or liver disease.

  • tell your doctor if you are pregnant, think you may be pregnant, or plan to become pregnant, or are breast-feeding. If you become pregnant while taking budesonide, call your doctor.

  • if you are having surgery, including dental surgery, tell the doctor or dentist that you are taking budesonide.

  • tell your doctor if you have never had chicken pox or measles and you have not been vaccinated against these infections. Stay away from people who are sick, especially people who have chicken pox or measles. If you are exposed to one of these infections or if you develop symptoms of one of these infections, call your doctor right away. You may need treatment to protect you from these infections.

Do not eat grapefruit or drink grapefruit juice while taking this medication.

Take the missed dose as soon as you remember it. However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.

  • Budesonide may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

    • headache

    • dizziness

    • runny nose, sneezing, coughing

    • nausea

    • indigestion

    • abdominal pain

    • dry, itchy skin

    • gas

    • vomiting

    • fatigue

    • back pain

    • pain

    • muscle cramps

  • Some side effects can be serious. If you experience any of these symptoms, call your doctor immediately:

    • itching

    • skin rash

    • fever

    • swelling of face and neck

    • difficulty breathing

    • severe headache

    • changes in vision

    • acne

    • bruising

    • swelling of the legs or arms

    • fatty pad or hump between your shoulders

    • pink or purple stretch marks on the skin of your stomach, thighs, breasts or arms

  • Budesonide may cause other side effects. Call your doctor if you have any unusual problems while taking this medication or if your symptoms get worse.

  • If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).

Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat and moisture (not in the bathroom).

Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA's Safe Disposal of Medicines website (http://goo.gl/c4Rm4p) for more information if you do not have access to a take-back program.

It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach. http://www.upandaway.org

In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.

Keep all appointments with your doctor.

Before having any laboratory test, tell your doctor and the laboratory personnel that you are taking budesonide.

Do not let anyone else take your medication. Ask your pharmacist any questions you have about refilling your prescription.

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

Drug Interaction
Moxifloxacin Moxifloxacin The risk or severity of tendinopathy can be increased when Budesonide is combined with Moxifloxacin.
Repaglinide Repaglinide The risk or severity of hyperglycemia can be increased when Budesonide is combined with Repaglinide.
Insulin Glargine (rDNA origin) Injection Insulin Glargine (rDNA origin) Injection The risk or severity of hyperglycemia can be increased when Budesonide is combined with Insulin glargine.
Leflunomide Leflunomide The risk or severity of adverse effects can be increased when Budesonide is combined with Leflunomide.
Delavirdine Delavirdine The metabolism of Budesonide can be decreased when combined with Delavirdine.
Nevirapine Nevirapine The metabolism of Nevirapine can be increased when combined with Budesonide.
Atorvastatin Atorvastatin The metabolism of Atorvastatin can be increased when combined with Budesonide.
Aminophylline Aminophylline The metabolism of Aminophylline can be increased when combined with Budesonide.
Calcium Carbonate Calcium Carbonate The bioavailability of Budesonide can be decreased when combined with Calcium carbonate.
Cilostazol Cilostazol The metabolism of Cilostazol can be increased when combined with Budesonide.
Clopidogrel Clopidogrel The metabolism of Clopidogrel can be increased when combined with Budesonide.
Erythromycin and Sulfisoxazole Erythromycin and Sulfisoxazole The serum concentration of Erythromycin can be increased when it is combined with Budesonide.
Estrogen and Progestin (Oral Contraceptives) Estrogen and Progestin (Oral Contraceptives) The serum concentration of Budesonide can be increased when it is combined with Conjugated estrogens.
Fenofibrate Fenofibrate The metabolism of Fenofibrate can be increased when combined with Budesonide.
Guanfacine Guanfacine Guanfacine may decrease the excretion rate of Budesonide which could result in a higher serum level.
Magnesium Hydroxide Magnesium Hydroxide The bioavailability of Budesonide can be decreased when combined with Magnesium hydroxide.
Magnesium Oxide Magnesium Oxide The bioavailability of Budesonide can be decreased when combined with Magnesium oxide.
Miglitol Miglitol The risk or severity of hyperglycemia can be increased when Budesonide is combined with Miglitol.
Mycophenolate Mycophenolate The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Budesonide.
Olsalazine Olsalazine The risk or severity of gastrointestinal irritation can be increased when Olsalazine is combined with Budesonide.
Potassium Potassium Potassium may increase the excretion rate of Budesonide which could result in a lower serum level and potentially a reduction in efficacy.
Prednisone Prednisone The risk or severity of adverse effects can be increased when Prednisone is combined with Budesonide.
Ranitidine Ranitidine Ranitidine can cause a decrease in the absorption of Budesonide resulting in a reduced serum concentration and potentially a decrease in efficacy.
Reserpine Reserpine Reserpine may decrease the excretion rate of Budesonide which could result in a higher serum level.
Rizatriptan Rizatriptan Rizatriptan may decrease the excretion rate of Budesonide which could result in a higher serum level.
Sumatriptan Sumatriptan Sumatriptan may decrease the excretion rate of Budesonide which could result in a higher serum level.
Tacrolimus Tacrolimus Tacrolimus may increase the immunosuppressive activities of Budesonide.
Triamcinolone Triamcinolone The risk or severity of adverse effects can be increased when Triamcinolone is combined with Budesonide.
Ampicillin Injection Ampicillin Injection Ampicillin may decrease the excretion rate of Budesonide which could result in a higher serum level.
Doxycycline Injection Doxycycline Injection Doxycycline may decrease the excretion rate of Budesonide which could result in a higher serum level.
Famotidine Injection Famotidine Injection Famotidine can cause a decrease in the absorption of Budesonide resulting in a reduced serum concentration and potentially a decrease in efficacy.
Fluconazole Injection Fluconazole Injection Fluconazole may decrease the excretion rate of Budesonide which could result in a higher serum level.
Foscarnet Injection Foscarnet Injection Foscarnet may decrease the excretion rate of Budesonide which could result in a higher serum level.
Hydromorphone Injection Hydromorphone Injection Hydromorphone may decrease the excretion rate of Budesonide which could result in a higher serum level.
Interferon Beta-1b Injection Interferon Beta-1b Injection The risk or severity of adverse effects can be increased when Interferon beta-1b is combined with Budesonide.
Interferon Gamma-1b Injection Interferon Gamma-1b Injection The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Budesonide.
Levofloxacin Injection Levofloxacin Injection The risk or severity of tendinopathy can be increased when Levofloxacin is combined with Budesonide.
Meperidine Injection Meperidine Injection The metabolism of Budesonide can be increased when combined with Meperidine.
Methylprednisolone Injection Methylprednisolone Injection The risk or severity of adverse effects can be increased when Methylprednisolone is combined with Budesonide.
Metoclopramide Injection Metoclopramide Injection The therapeutic efficacy of Metoclopramide can be decreased when used in combination with Budesonide.
Metronidazole Injection Metronidazole Injection The metabolism of Metronidazole can be increased when combined with Budesonide.
Pamidronate Injection Pamidronate Injection Pamidronic acid may decrease the excretion rate of Budesonide which could result in a higher serum level.
Vancomycin Injection Vancomycin Injection Budesonide may decrease the excretion rate of Vancomycin which could result in a higher serum level.
Zidovudine Injection Zidovudine Injection The risk or severity of adverse effects can be increased when Zidovudine is combined with Budesonide.
Altretamine Altretamine Amphetamine may decrease the excretion rate of Budesonide which could result in a higher serum level.
Cefuroxime Cefuroxime Cefuroxime may decrease the excretion rate of Budesonide which could result in a higher serum level.
Cyclosporine Cyclosporine Budesonide may increase the immunosuppressive activities of Cyclosporine.
Ondansetron Ondansetron The metabolism of Ondansetron can be increased when combined with Budesonide.
Torsemide Torsemide Budesonide may increase the excretion rate of Torasemide which could result in a lower serum level and potentially a reduction in efficacy.
Olanzapine Olanzapine Olanzapine can cause a decrease in the absorption of Budesonide resulting in a reduced serum concentration and potentially a decrease in efficacy.
Dofetilide Dofetilide The metabolism of Dofetilide can be increased when combined with Budesonide.
Hydroxychloroquine Hydroxychloroquine The risk or severity of adverse effects can be increased when Budesonide is combined with Hydroxychloroquine.
Meloxicam Meloxicam The risk or severity of gastrointestinal irritation can be increased when Budesonide is combined with Meloxicam.
Pantoprazole Pantoprazole Pantoprazole can cause a decrease in the absorption of Budesonide resulting in a reduced serum concentration and potentially a decrease in efficacy.
Telmisartan Telmisartan Telmisartan may decrease the excretion rate of Budesonide which could result in a higher serum level.
Temozolomide Temozolomide The risk or severity of adverse effects can be increased when Temozolomide is combined with Budesonide.
Zaleplon Zaleplon The metabolism of Zaleplon can be increased when combined with Budesonide.
Anakinra Anakinra The risk or severity of adverse effects can be increased when Anakinra is combined with Budesonide.
Linezolid Linezolid The risk or severity of adverse effects can be increased when Linezolid is combined with Budesonide.
Rivastigmine Rivastigmine The therapeutic efficacy of Rivastigmine can be decreased when used in combination with Budesonide.
Etanercept Injection Etanercept Injection The risk or severity of adverse effects can be increased when Etanercept is combined with Budesonide.
Perindopril Perindopril Perindopril may decrease the excretion rate of Budesonide which could result in a higher serum level.
Tenofovir Tenofovir The metabolism of Tenofovir can be increased when combined with Budesonide.
Choline Magnesium Trisalicylate Choline Magnesium Trisalicylate The risk or severity of gastrointestinal irritation can be increased when Choline magnesium trisalicylate is combined with Budesonide.
Sirolimus Sirolimus The serum concentration of Sirolimus can be increased when it is combined with Budesonide.
Dutasteride Dutasteride The metabolism of Dutasteride can be increased when combined with Budesonide.
Epinephrine Injection Epinephrine Injection The risk or severity of hypokalemia can be increased when Budesonide is combined with Epinephrine.
Epirubicin Epirubicin The risk or severity of adverse effects can be increased when Epirubicin is combined with Budesonide.
Eplerenone Eplerenone The metabolism of Eplerenone can be increased when combined with Budesonide.
Olmesartan Olmesartan Olmesartan may decrease the excretion rate of Budesonide which could result in a higher serum level.
Zonisamide Zonisamide The metabolism of Budesonide can be increased when combined with Zonisamide.
Adalimumab Injection Adalimumab Injection The risk or severity of adverse effects can be increased when Adalimumab is combined with Budesonide.
Aripiprazole Aripiprazole The metabolism of Aripiprazole can be increased when combined with Budesonide.
Atomoxetine Atomoxetine Atomoxetine may decrease the excretion rate of Budesonide which could result in a higher serum level.
Ezetimibe Ezetimibe Ezetimibe may decrease the excretion rate of Budesonide which could result in a higher serum level.
Glatiramer Injection Glatiramer Injection The risk or severity of adverse effects can be increased when Budesonide is combined with Glatiramer.
Atazanavir Atazanavir The metabolism of Atazanavir can be decreased when combined with Budesonide.
Almotriptan Almotriptan Almotriptan may decrease the excretion rate of Budesonide which could result in a higher serum level.
Mefloquine Mefloquine The therapeutic efficacy of Mefloquine can be decreased when used in combination with Budesonide.
Rosuvastatin Rosuvastatin The metabolism of Rosuvastatin can be increased when combined with Budesonide.
Vardenafil Vardenafil The metabolism of Vardenafil can be increased when combined with Budesonide.
Aprepitant Aprepitant The metabolism of Aprepitant can be increased when combined with Budesonide.
Emtricitabine Emtricitabine Emtricitabine may decrease the excretion rate of Budesonide which could result in a higher serum level.
Memantine Memantine The therapeutic efficacy of Budesonide can be decreased when used in combination with Memantine.
Tadalafil Tadalafil The metabolism of Tadalafil can be increased when combined with Budesonide.
Gemifloxacin Gemifloxacin The risk or severity of tendinopathy can be increased when Budesonide is combined with Gemifloxacin.
Progesterone Progesterone The serum concentration of Budesonide can be increased when it is combined with Progesterone.
Apomorphine Injection Apomorphine Injection The metabolism of Apomorphine can be increased when combined with Budesonide.
Infliximab Injection Infliximab Injection The risk or severity of adverse effects can be increased when Infliximab is combined with Budesonide.
Oxandrolone Oxandrolone The risk or severity of fluid retention can be increased when Budesonide is combined with Oxandrolone.
Duloxetine Duloxetine The metabolism of Duloxetine can be increased when combined with Budesonide.
Norethindrone Norethindrone The serum concentration of Budesonide can be increased when it is combined with Norethisterone.
Tinidazole Tinidazole Tinidazole may decrease the excretion rate of Budesonide which could result in a higher serum level.
Bosentan Bosentan Bosentan may decrease the excretion rate of Budesonide which could result in a higher serum level.
Cefditoren Cefditoren Cefdinir may decrease the excretion rate of Budesonide which could result in a higher serum level.
Natalizumab Injection Natalizumab Injection The risk or severity of adverse effects can be increased when Budesonide is combined with Natalizumab.
Cyanocobalamin Injection Cyanocobalamin Injection Hydroxocobalamin may decrease the excretion rate of Budesonide which could result in a higher serum level.
Erlotinib Erlotinib The serum concentration of Erlotinib can be decreased when it is combined with Budesonide.
Eszopiclone Eszopiclone The serum concentration of Eszopiclone can be decreased when it is combined with Budesonide.
Ganciclovir Ganciclovir Ganciclovir may decrease the excretion rate of Budesonide which could result in a higher serum level.
Insulin Aspart (rDNA Origin) Injection Insulin Aspart (rDNA Origin) Injection The risk or severity of hyperglycemia can be increased when Budesonide is combined with Insulin aspart.
Ribavirin Ribavirin Ribavirin may decrease the excretion rate of Budesonide which could result in a higher serum level.
Valganciclovir Valganciclovir Budesonide may decrease the excretion rate of Valganciclovir which could result in a higher serum level.
Voriconazole Voriconazole The metabolism of Budesonide can be decreased when combined with Voriconazole.
Adefovir Adefovir Adefovir may decrease the excretion rate of Budesonide which could result in a higher serum level.
Dextroamphetamine Dextroamphetamine Amphetamine may decrease the excretion rate of Budesonide which could result in a higher serum level.
Peginterferon Alfa-2a Injection Peginterferon Alfa-2a Injection The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Budesonide.
Peginterferon Alfa-2b (PEG-Intron) Peginterferon Alfa-2b (PEG-Intron) The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Budesonide.
Pramlintide Injection Pramlintide Injection The risk or severity of hyperglycemia can be increased when Budesonide is combined with Pramlintide.
Exenatide Injection Exenatide Injection The risk or severity of hyperglycemia can be increased when Budesonide is combined with Exenatide.
Ramelteon Ramelteon Ramelteon may decrease the excretion rate of Budesonide which could result in a higher serum level.
Fentanyl Fentanyl The metabolism of Fentanyl can be increased when combined with Budesonide.
Pregabalin Pregabalin Pregabalin may decrease the excretion rate of Budesonide which could result in a higher serum level.
Deferasirox Deferasirox The risk or severity of gastrointestinal ulceration and gastrointestinal irritation can be increased when Budesonide is combined with Deferasirox.
Phenylephrine Phenylephrine The risk or severity of hypertension can be increased when Budesonide is combined with Phenylephrine.
Tipranavir Tipranavir The metabolism of Tipranavir can be decreased when combined with Budesonide.
Insulin Detemir (rDNA Origin) Injection Insulin Detemir (rDNA Origin) Injection The risk or severity of hyperglycemia can be increased when Budesonide is combined with Insulin detemir.
Ranolazine Ranolazine The metabolism of Budesonide can be increased when combined with Ranolazine.
Abatacept Injection Abatacept Injection The risk or severity of adverse effects can be increased when Budesonide is combined with Abatacept.
Rasagiline Rasagiline Budesonide may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Imatinib Imatinib The risk or severity of adverse effects can be increased when Budesonide is combined with Imatinib.
Sitagliptin Sitagliptin The risk or severity of hyperglycemia can be increased when Budesonide is combined with Sitagliptin.
Varenicline Varenicline Budesonide may decrease the excretion rate of Varenicline which could result in a higher serum level.
Bevacizumab Injection Bevacizumab Injection The risk or severity of adverse effects can be increased when Bevacizumab is combined with Budesonide.
Gefitinib Gefitinib The metabolism of Gefitinib can be increased when combined with Budesonide.
Albuterol Albuterol The risk or severity of hypokalemia can be increased when Budesonide is combined with Salbutamol.
Paliperidone Paliperidone The metabolism of Paliperidone can be increased when combined with Budesonide.
Bortezomib Bortezomib The metabolism of Budesonide can be increased when combined with Bortezomib.
Clofarabine Injection Clofarabine Injection The risk or severity of adverse effects can be increased when Clofarabine is combined with Budesonide.
Hepatitis B Vaccine Hepatitis B Vaccine The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Budesonide.
Influenza Vaccine, Inactivated or Recombinant Influenza Vaccine, Inactivated or Recombinant The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Budesonide.
Influenza Vaccine, Live Intranasal Influenza Vaccine, Live Intranasal The therapeutic efficacy of Budesonide can be decreased when used in combination with Typhoid Vaccine Live.
Live Shingles (Zoster) Vaccine (ZVL) Live Shingles (Zoster) Vaccine (ZVL) The therapeutic efficacy of Budesonide can be decreased when used in combination with Varicella Zoster Vaccine (Live/attenuated).
Insulin Glulisine (rDNA origin) Injection Insulin Glulisine (rDNA origin) Injection The risk or severity of hyperglycemia can be increased when Budesonide is combined with Insulin glulisine.
Lubiprostone Lubiprostone Lubiprostone may decrease the excretion rate of Budesonide which could result in a higher serum level.
Oxaliplatin Injection Oxaliplatin Injection The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Budesonide.
Posaconazole Posaconazole The metabolism of Budesonide can be decreased when combined with Posaconazole.
Rituximab Injection Rituximab Injection The risk or severity of adverse effects can be increased when Rituximab is combined with Budesonide.
Bismuth Subsalicylate Bismuth Subsalicylate The serum concentration of Budesonide can be decreased when it is combined with Bismuth subsalicylate.
Darunavir Darunavir The metabolism of Darunavir can be decreased when combined with Budesonide.
Pemetrexed Injection Pemetrexed Injection The risk or severity of adverse effects can be increased when Pemetrexed is combined with Budesonide.
Retapamulin Retapamulin The metabolism of Retapamulin can be increased when combined with Budesonide.
Vorinostat Vorinostat The risk or severity of adverse effects can be increased when Budesonide is combined with Vorinostat.
Sorafenib Sorafenib The metabolism of Sorafenib can be increased when combined with Budesonide.
Sunitinib Sunitinib The risk or severity of hyperglycemia can be increased when Sunitinib is combined with Budesonide.
Lapatinib Lapatinib The metabolism of Lapatinib can be increased when combined with Budesonide.
Levocetirizine Levocetirizine Budesonide may decrease the excretion rate of Levocetirizine which could result in a higher serum level.
Pegaptanib Injection Pegaptanib Injection Budesonide may decrease the excretion rate of Pegaptanib which could result in a higher serum level.
Dasatinib Dasatinib The metabolism of Dasatinib can be increased when combined with Budesonide.
Azacitidine Injection Azacitidine Injection The risk or severity of adverse effects can be increased when Azacitidine is combined with Budesonide.
Temsirolimus Temsirolimus The serum concentration of Temsirolimus can be increased when it is combined with Budesonide.
Nelarabine Injection Nelarabine Injection The risk or severity of adverse effects can be increased when Budesonide is combined with Nelarabine.
Lenalidomide Lenalidomide The risk or severity of adverse effects can be increased when Lenalidomide is combined with Budesonide.
Nilotinib Nilotinib The metabolism of Nilotinib can be decreased when combined with Budesonide.
Bexarotene Bexarotene The risk or severity of adverse effects can be increased when Bexarotene is combined with Budesonide.
Chloramphenicol Injection Chloramphenicol Injection The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Budesonide.
Decitabine Injection Decitabine Injection The risk or severity of adverse effects can be increased when Budesonide is combined with Decitabine.
Desmopressin Desmopressin Desmopressin may decrease the excretion rate of Budesonide which could result in a higher serum level.
Betaine Betaine The therapeutic efficacy of Glycine betaine can be decreased when used in combination with Budesonide.
Doripenem Injection Doripenem Injection Budesonide may decrease the excretion rate of Doripenem which could result in a higher serum level.
Arsenic Trioxide Injection Arsenic Trioxide Injection The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Budesonide.
Mitoxantrone Injection Mitoxantrone Injection The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Budesonide.
Desvenlafaxine Desvenlafaxine Budesonide may decrease the excretion rate of Desvenlafaxine which could result in a higher serum level.
Cevimeline Cevimeline Cevimeline may decrease the excretion rate of Budesonide which could result in a higher serum level.
Tretinoin Tretinoin The risk or severity of adverse effects can be increased when Budesonide is combined with Tretinoin.
Bendamustine Injection Bendamustine Injection The risk or severity of adverse effects can be increased when Budesonide is combined with Bendamustine.
Certolizumab Injection Certolizumab Injection The risk or severity of adverse effects can be increased when Budesonide is combined with Certolizumab pegol.
Ixabepilone Injection Ixabepilone Injection The serum concentration of Ixabepilone can be increased when it is combined with Budesonide.
Irinotecan Injection Irinotecan Injection The metabolism of Irinotecan can be increased when combined with Budesonide.
Daptomycin Injection Daptomycin Injection Daptomycin may decrease the excretion rate of Budesonide which could result in a higher serum level.
Estramustine Estramustine The risk or severity of adverse effects can be increased when Estramustine is combined with Budesonide.
Praziquantel Praziquantel The metabolism of Praziquantel can be increased when combined with Budesonide.
Mitotane Mitotane The serum concentration of Budesonide can be decreased when it is combined with Mitotane.
Methylnaltrexone Injection Methylnaltrexone Injection Budesonide may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.
Alemtuzumab Injection (Chronic Lymphocytic Leukemia) Alemtuzumab Injection (Chronic Lymphocytic Leukemia) The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Budesonide.
Rufinamide Rufinamide The metabolism of Rufinamide can be increased when combined with Budesonide.
Midazolam Midazolam The metabolism of Midazolam can be increased when combined with Budesonide.
Dexrazoxane Injection Dexrazoxane Injection The risk or severity of adverse effects can be increased when Dexrazoxane is combined with Budesonide.
Ibritumomab Injection Ibritumomab Injection The risk or severity of adverse effects can be increased when Ibritumomab tiuxetan is combined with Budesonide.
Milnacipran Milnacipran The metabolism of Milnacipran can be increased when combined with Budesonide.
Dexlansoprazole Dexlansoprazole Dexlansoprazole can cause a decrease in the absorption of Budesonide resulting in a reduced serum concentration and potentially a decrease in efficacy.
Plerixafor Injection Plerixafor Injection Budesonide may decrease the excretion rate of Plerixafor which could result in a higher serum level.
Fesoterodine Fesoterodine Budesonide may decrease the excretion rate of Fesoterodine which could result in a higher serum level.
Iloperidone Iloperidone The metabolism of Iloperidone can be increased when combined with Budesonide.
Prasugrel Prasugrel Budesonide may decrease the excretion rate of Prasugrel which could result in a higher serum level.
Lacosamide Lacosamide The metabolism of Lacosamide can be increased when combined with Budesonide.
Everolimus Everolimus The serum concentration of Everolimus can be increased when it is combined with Budesonide.
Tolvaptan (low blood sodium) Tolvaptan (low blood sodium) The metabolism of Budesonide can be increased when combined with Tolvaptan.
Dronedarone Dronedarone The metabolism of Budesonide can be increased when combined with Dronedarone.
Pralatrexate Injection Pralatrexate Injection The risk or severity of adverse effects can be increased when Budesonide is combined with Pralatrexate.
Palonosetron Injection Palonosetron Injection Palonosetron may decrease the excretion rate of Budesonide which could result in a higher serum level.
Saxagliptin Saxagliptin The risk or severity of hyperglycemia can be increased when Budesonide is combined with Saxagliptin.
Telavancin Injection Telavancin Injection Budesonide may decrease the excretion rate of Telavancin which could result in a higher serum level.
Romidepsin Injection Romidepsin Injection The metabolism of Romidepsin can be increased when combined with Budesonide.
Topotecan Topotecan The risk or severity of adverse effects can be increased when Topotecan is combined with Budesonide.
Golimumab Injection Golimumab Injection The risk or severity of adverse effects can be increased when Budesonide is combined with Golimumab.
Pazopanib Pazopanib The metabolism of Pazopanib can be increased when combined with Budesonide.
Asenapine Asenapine Asenapine can cause a decrease in the absorption of Budesonide resulting in a reduced serum concentration and potentially a decrease in efficacy.
Pitavastatin Pitavastatin Budesonide may decrease the excretion rate of Pitavastatin which could result in a higher serum level.
Albendazole Albendazole The metabolism of Albendazole can be increased when combined with Budesonide.
Ulipristal Ulipristal The serum concentration of Budesonide can be increased when it is combined with Ulipristal.
Levonorgestrel Levonorgestrel The serum concentration of Levonorgestrel can be increased when it is combined with Budesonide.
Denosumab Injection Denosumab Injection The risk or severity of adverse effects can be increased when Denosumab is combined with Budesonide.
Liraglutide Injection Liraglutide Injection The risk or severity of hyperglycemia can be increased when Budesonide is combined with Liraglutide.
Tocilizumab Injection Tocilizumab Injection The risk or severity of adverse effects can be increased when Budesonide is combined with Tocilizumab.
Dalfampridine Dalfampridine Budesonide may decrease the excretion rate of Dalfampridine which could result in a higher serum level.
Fingolimod Fingolimod Budesonide may increase the immunosuppressive activities of Fingolimod.
Eribulin Injection Eribulin Injection The risk or severity of adverse effects can be increased when Budesonide is combined with Eribulin.
Cabazitaxel Injection Cabazitaxel Injection The metabolism of Budesonide can be increased when combined with Cabazitaxel.
Ceftaroline Injection Ceftaroline Injection Ceftaroline fosamil may decrease the excretion rate of Budesonide which could result in a higher serum level.
Acetaminophen Injection Acetaminophen Injection Acetaminophen may decrease the excretion rate of Budesonide which could result in a higher serum level.
Ipilimumab Injection Ipilimumab Injection Budesonide may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Denileukin Diftitox Injection Denileukin Diftitox Injection The risk or severity of adverse effects can be increased when Aldesleukin is combined with Budesonide.
Sipuleucel-T Injection Sipuleucel-T Injection The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Budesonide.
Terbutaline Injection Terbutaline Injection The therapeutic efficacy of Terbutaline can be decreased when used in combination with Budesonide.
Belimumab Injection Belimumab Injection The risk or severity of adverse effects can be increased when Budesonide is combined with Belimumab.
Busulfan Injection Busulfan Injection The metabolism of Busulfan can be increased when combined with Budesonide.
Roflumilast Roflumilast Roflumilast may increase the immunosuppressive activities of Budesonide.
Linagliptin Linagliptin The risk or severity of hyperglycemia can be increased when Linagliptin is combined with Budesonide.
Cyclophosphamide Injection Cyclophosphamide Injection The metabolism of Cyclophosphamide can be increased when combined with Budesonide.
Rivaroxaban Rivaroxaban The metabolism of Rivaroxaban can be increased when combined with Budesonide.
Brentuximab Vedotin Injection Brentuximab Vedotin Injection The metabolism of Brentuximab vedotin can be increased when combined with Budesonide.
Ruxolitinib Ruxolitinib The metabolism of Ruxolitinib can be increased when combined with Budesonide.
Vandetanib Vandetanib The metabolism of Vandetanib can be increased when combined with Budesonide.
Clobazam Clobazam Clobazam may decrease the excretion rate of Budesonide which could result in a higher serum level.
Vemurafenib Vemurafenib The metabolism of Vemurafenib can be increased when combined with Budesonide.
Belatacept Injection Belatacept Injection The risk or severity of adverse effects can be increased when Budesonide is combined with Belatacept.
Ivacaftor Ivacaftor The metabolism of Ivacaftor can be increased when combined with Budesonide.
Basiliximab Injection Basiliximab Injection The risk or severity of adverse effects can be increased when Basiliximab is combined with Budesonide.
Deferiprone Deferiprone Budesonide may decrease the excretion rate of Deferiprone which could result in a higher serum level.
Axitinib Axitinib The metabolism of Axitinib can be increased when combined with Budesonide.
Crizotinib Crizotinib The metabolism of Crizotinib can be increased when combined with Budesonide.
Melphalan Injection Melphalan Injection The risk or severity of adverse effects can be increased when Melphalan is combined with Budesonide.
Cabergoline Cabergoline The metabolism of Cabergoline can be increased when combined with Budesonide.
Naloxone Injection Naloxone Injection The metabolism of Budesonide can be decreased when combined with Naloxone.
Ambrisentan Ambrisentan The metabolism of Ambrisentan can be increased when combined with Budesonide.
Eculizumab Injection Eculizumab Injection The risk or severity of adverse effects can be increased when Budesonide is combined with Eculizumab.
Fondaparinux Injection Fondaparinux Injection Fondaparinux may decrease the excretion rate of Budesonide which could result in a higher serum level.
Carfilzomib Injection Carfilzomib Injection The risk or severity of adverse effects can be increased when Budesonide is combined with Carfilzomib.
Enzalutamide Enzalutamide The metabolism of Enzalutamide can be increased when combined with Budesonide.
Mirabegron Mirabegron Budesonide may decrease the excretion rate of Mirabegron which could result in a higher serum level.
Regorafenib Regorafenib The metabolism of Regorafenib can be increased when combined with Budesonide.
Bosutinib Bosutinib The metabolism of Bosutinib can be increased when combined with Budesonide.
Corticotropin, Repository Injection Corticotropin, Repository Injection The risk or severity of adverse effects can be increased when Budesonide is combined with Corticotropin.
Teriflunomide Teriflunomide The risk or severity of adverse effects can be increased when Budesonide is combined with Teriflunomide.
Lorcaserin Lorcaserin The risk or severity of hyperglycemia can be increased when Budesonide is combined with Mecasermin.
Teduglutide Injection Teduglutide Injection Budesonide may decrease the excretion rate of Teduglutide which could result in a higher serum level.
Tofacitinib Tofacitinib Budesonide may increase the immunosuppressive activities of Tofacitinib.
Alogliptin Alogliptin The risk or severity of hyperglycemia can be increased when Budesonide is combined with Alogliptin.
Dimethyl Fumarate Dimethyl Fumarate The risk or severity of adverse effects can be increased when Budesonide is combined with Dimethyl fumarate.
Ponatinib Ponatinib The metabolism of Budesonide can be increased when combined with Ponatinib.
Pomalidomide Pomalidomide The metabolism of Pomalidomide can be increased when combined with Budesonide.
Ado-trastuzumab Emtansine Injection Ado-trastuzumab Emtansine Injection The metabolism of Trastuzumab emtansine can be increased when combined with Budesonide.
Apixaban Apixaban The metabolism of Apixaban can be increased when combined with Budesonide.
Canagliflozin Canagliflozin The risk or severity of hyperglycemia can be increased when Canagliflozin is combined with Budesonide.
Methazolamide Methazolamide Methazolamide may increase the excretion rate of Budesonide which could result in a lower serum level and potentially a reduction in efficacy.
Dabrafenib Dabrafenib The metabolism of Dabrafenib can be increased when combined with Budesonide.
Trametinib Trametinib Budesonide may decrease the excretion rate of Trametinib which could result in a higher serum level.
Levomilnacipran Levomilnacipran The metabolism of Levomilnacipran can be increased when combined with Budesonide.
Ertapenem Injection Ertapenem Injection Ertapenem may decrease the excretion rate of Budesonide which could result in a higher serum level.
Vortioxetine Vortioxetine The metabolism of Vortioxetine can be increased when combined with Budesonide.
Perampanel Perampanel The metabolism of Perampanel can be increased when combined with Budesonide.
Ibrutinib Ibrutinib The risk or severity of adverse effects can be increased when Budesonide is combined with Ibrutinib.
Lomitapide Lomitapide The metabolism of Lomitapide can be increased when combined with Budesonide.
Ketorolac Injection Ketorolac Injection The risk or severity of gastrointestinal irritation can be increased when Ketorolac is combined with Budesonide.
Obinutuzumab Injection Obinutuzumab Injection The risk or severity of adverse effects can be increased when Budesonide is combined with Obinutuzumab.
Simeprevir Simeprevir Simeprevir may decrease the excretion rate of Budesonide which could result in a higher serum level.
Sofosbuvir Sofosbuvir Budesonide may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.
Dapagliflozin Dapagliflozin The risk or severity of hyperglycemia can be increased when Budesonide is combined with Dapagliflozin.
Apremilast Apremilast The risk or severity of adverse effects can be increased when Budesonide is combined with Apremilast.
Droxidopa Droxidopa The risk or severity of hypokalemia can be increased when Budesonide is combined with Droxidopa.
Ceritinib Ceritinib The risk or severity of hyperglycemia can be increased when Budesonide is combined with Ceritinib.
Siltuximab Injection Siltuximab Injection The risk or severity of adverse effects can be increased when Budesonide is combined with Siltuximab.
Albiglutide Injection Albiglutide Injection The risk or severity of hyperglycemia can be increased when Budesonide is combined with Albiglutide.
Vedolizumab Injection Vedolizumab Injection The risk or severity of adverse effects can be increased when Budesonide is combined with Vedolizumab.
Belinostat Injection Belinostat Injection The risk or severity of adverse effects can be increased when Budesonide is combined with Belinostat.
Idelalisib Idelalisib The metabolism of Idelalisib can be increased when combined with Budesonide.
Testosterone Injection Testosterone Injection The risk or severity of edema formation can be increased when Testosterone is combined with Budesonide.
Empagliflozin Empagliflozin The risk or severity of hyperglycemia can be increased when Budesonide is combined with Empagliflozin.
Vorapaxar Vorapaxar The metabolism of Vorapaxar can be increased when combined with Budesonide.
Suvorexant Suvorexant The metabolism of Suvorexant can be increased when combined with Budesonide.
Dulaglutide Injection Dulaglutide Injection The risk or severity of hyperglycemia can be increased when Budesonide is combined with Dulaglutide.
Edoxaban Edoxaban Budesonide may decrease the excretion rate of Edoxaban which could result in a higher serum level.
Peginterferon Beta-1a Injection Peginterferon Beta-1a Injection The risk or severity of adverse effects can be increased when Budesonide is combined with Peginterferon beta-1a.
Olaparib Olaparib The metabolism of Olaparib can be increased when combined with Budesonide.
Blinatumomab Injection Blinatumomab Injection The risk or severity of adverse effects can be increased when Budesonide is combined with Blinatumomab.
Methamphetamine Methamphetamine Budesonide may decrease the excretion rate of Metamfetamine which could result in a higher serum level.
Tasimelteon Tasimelteon The metabolism of Tasimelteon can be increased when combined with Budesonide.
Pirfenidone Pirfenidone The risk or severity of adverse effects can be increased when Budesonide is combined with Pirfenidone.
Nintedanib Nintedanib The metabolism of Nintedanib can be increased when combined with Budesonide.
Secukinumab Injection Secukinumab Injection The risk or severity of adverse effects can be increased when Budesonide is combined with Secukinumab.
Risperidone Injection Risperidone Injection The metabolism of Risperidone can be increased when combined with Budesonide.
Palbociclib Palbociclib The metabolism of Palbociclib can be increased when combined with Budesonide.
Insulin Human Inhalation Insulin Human Inhalation The risk or severity of hyperglycemia can be increased when Budesonide is combined with Insulin human.
Lenvatinib Lenvatinib Lenvatinib may decrease the excretion rate of Budesonide which could result in a higher serum level.
Panobinostat Panobinostat The metabolism of Panobinostat can be increased when combined with Budesonide.
Dinutuximab Injection Dinutuximab Injection The risk or severity of adverse effects can be increased when Budesonide is combined with Dinutuximab.
Haloperidol Injection Haloperidol Injection The serum concentration of Haloperidol can be increased when it is combined with Budesonide.
Deoxycholic Acid Injection Deoxycholic Acid Injection Deoxycholic acid may increase the excretion rate of Budesonide which could result in a lower serum level and potentially a reduction in efficacy.
Amiloride Amiloride Amiloride may increase the excretion rate of Budesonide which could result in a lower serum level and potentially a reduction in efficacy.
Macitentan Macitentan Budesonide may decrease the excretion rate of Macitentan which could result in a higher serum level.
Sonidegib Sonidegib The metabolism of Sonidegib can be increased when combined with Budesonide.
Prednisolone Prednisolone The risk or severity of adverse effects can be increased when Prednisolone is combined with Budesonide.
Daclatasvir Daclatasvir The metabolism of Budesonide can be increased when combined with Daclatasvir.
Ziprasidone Injection Ziprasidone Injection The metabolism of Ziprasidone can be increased when combined with Budesonide.
Penicillin G Procaine Injection Penicillin G Procaine Injection Budesonide may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.
Insulin Degludec (rDNA Origin) Injection Insulin Degludec (rDNA Origin) Injection The risk or severity of hyperglycemia can be increased when Budesonide is combined with Insulin degludec.
Cobimetinib Cobimetinib The metabolism of Cobimetinib can be increased when combined with Budesonide.
Mepolizumab Injection Mepolizumab Injection The risk or severity of adverse effects can be increased when Budesonide is combined with Mepolizumab.
Trabectedin Injection Trabectedin Injection The metabolism of Trabectedin can be increased when combined with Budesonide.
Osimertinib Osimertinib The metabolism of Osimertinib can be increased when combined with Budesonide.
Alectinib Alectinib The metabolism of Alectinib can be increased when combined with Budesonide.
Ixazomib Ixazomib The metabolism of Ixazomib can be increased when combined with Budesonide.
Lesinurad Lesinurad Budesonide may decrease the excretion rate of Lesinurad which could result in a higher serum level.
Amphotericin B Liposomal Injection Amphotericin B Liposomal Injection The risk or severity of hypokalemia can be increased when Budesonide is combined with Amphotericin B.
Dexamethasone Injection Dexamethasone Injection The risk or severity of adverse effects can be increased when Budesonide is combined with Dexamethasone.
Ixekizumab Injection Ixekizumab Injection The risk or severity of adverse effects can be increased when Budesonide is combined with Ixekizumab.
Brivaracetam Injection Brivaracetam Injection Budesonide may decrease the excretion rate of Brivaracetam which could result in a higher serum level.
Venetoclax Venetoclax The metabolism of Venetoclax can be increased when combined with Budesonide.
Cobicistat Cobicistat The metabolism of Cobicistat can be decreased when combined with Budesonide.
Calcifediol Calcifediol The therapeutic efficacy of Calcifediol can be decreased when used in combination with Budesonide.
Ergocalciferol Ergocalciferol The therapeutic efficacy of Ergocalciferol can be decreased when used in combination with Budesonide.
Doxercalciferol Doxercalciferol The therapeutic efficacy of Doxercalciferol can be decreased when used in combination with Budesonide.
Furosemide Injection Furosemide Injection Furosemide may increase the excretion rate of Budesonide which could result in a lower serum level and potentially a reduction in efficacy.
Lixisenatide Injection Lixisenatide Injection The risk or severity of hyperglycemia can be increased when Budesonide is combined with Lixisenatide.
Ribociclib Ribociclib The metabolism of Ribociclib can be decreased when combined with Budesonide.
Brodalumab Injection Brodalumab Injection The risk or severity of adverse effects can be increased when Budesonide is combined with Brodalumab.
Brigatinib Brigatinib The metabolism of Brigatinib can be increased when combined with Budesonide.
Doxepin (Insomnia) Doxepin (Insomnia) Budesonide can cause a decrease in the absorption of Doxepin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Deutetrabenazine Deutetrabenazine The metabolism of Deutetrabenazine can be increased when combined with Budesonide.
Valbenazine Valbenazine The metabolism of Valbenazine can be increased when combined with Budesonide.
Deflazacort Deflazacort The risk or severity of adverse effects can be increased when Budesonide is combined with Deflazacort.
Ocrelizumab Injection Ocrelizumab Injection The risk or severity of adverse effects can be increased when Budesonide is combined with Ocrelizumab.
Durvalumab Injection Durvalumab Injection The therapeutic efficacy of Durvalumab can be decreased when used in combination with Budesonide.
Naldemedine Naldemedine Budesonide may decrease the excretion rate of Naldemedine which could result in a higher serum level.
Sarilumab Injection Sarilumab Injection The risk or severity of adverse effects can be increased when Budesonide is combined with Sarilumab.
Midostaurin Midostaurin The metabolism of Budesonide can be decreased when combined with Midostaurin.
Neratinib Neratinib The metabolism of Neratinib can be increased when combined with Budesonide.
Guselkumab Injection Guselkumab Injection The risk or severity of adverse effects can be increased when Budesonide is combined with Guselkumab.
Enasidenib Enasidenib The metabolism of Enasidenib can be increased when combined with Budesonide.
Aprepitant/Fosaprepitant Injection Aprepitant/Fosaprepitant Injection The metabolism of Fosaprepitant can be increased when combined with Budesonide.
Benznidazole Benznidazole Budesonide may decrease the excretion rate of Benznidazole which could result in a higher serum level.
Copanlisib Injection Copanlisib Injection The metabolism of Copanlisib can be increased when combined with Budesonide.
Delafloxacin Delafloxacin The risk or severity of tendinopathy can be increased when Budesonide is combined with Delafloxacin.
Abemaciclib Abemaciclib The metabolism of Abemaciclib can be increased when combined with Budesonide.
Acalabrutinib Acalabrutinib The metabolism of Acalabrutinib can be increased when combined with Budesonide.
Gemtuzumab Ozogamicin Injection Gemtuzumab Ozogamicin Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Budesonide.
Letermovir Letermovir Letermovir may decrease the excretion rate of Budesonide which could result in a higher serum level.
Semaglutide Injection Semaglutide Injection The risk or severity of hyperglycemia can be increased when Budesonide is combined with Semaglutide.
Ertugliflozin Ertugliflozin The risk or severity of hyperglycemia can be increased when Ertugliflozin is combined with Budesonide.
Buprenorphine Injection Buprenorphine Injection The metabolism of Buprenorphine can be increased when combined with Budesonide.
Apalutamide Apalutamide Budesonide may decrease the excretion rate of Apalutamide which could result in a higher serum level.
Penicillamine Penicillamine The risk or severity of adverse effects can be increased when Penicillamine is combined with Budesonide.
Baricitinib Baricitinib The metabolism of Baricitinib can be increased when combined with Budesonide.
Lofexidine Lofexidine Budesonide may decrease the excretion rate of Lofexidine which could result in a higher serum level.
Plazomicin Injection Plazomicin Injection Budesonide may decrease the excretion rate of Plazomicin which could result in a higher serum level.
Ivosidenib Ivosidenib The metabolism of Ivosidenib can be increased when combined with Budesonide.
Doravirine Doravirine The metabolism of Doravirine can be increased when combined with Budesonide.
Cannabidiol Cannabidiol The metabolism of Cannabidiol can be increased when combined with Budesonide.
Dacomitinib Dacomitinib The metabolism of Dacomitinib can be increased when combined with Budesonide.
Duvelisib Duvelisib The metabolism of Duvelisib can be increased when combined with Budesonide.
Stiripentol Stiripentol The metabolism of Budesonide can be decreased when combined with Stiripentol.
Gilteritinib Gilteritinib The metabolism of Gilteritinib can be increased when combined with Budesonide.
Lorlatinib Lorlatinib The metabolism of Lorlatinib can be increased when combined with Budesonide.
Paclitaxel (with albumin) Injection Paclitaxel (with albumin) Injection The metabolism of Paclitaxel can be increased when combined with Budesonide.
Prucalopride Prucalopride The metabolism of Prucalopride can be increased when combined with Budesonide.
Ravulizumab-cwvz Injection Ravulizumab-cwvz Injection The risk or severity of adverse effects can be increased when Budesonide is combined with Ravulizumab.
Emapalumab-lzsg Injection Emapalumab-lzsg Injection The risk or severity of adverse effects can be increased when Budesonide is combined with Emapalumab.
Siponimod Siponimod The metabolism of Siponimod can be increased when combined with Budesonide.
Acyclovir Ophthalmic Acyclovir Ophthalmic Acyclovir may decrease the excretion rate of Budesonide which could result in a higher serum level.
Erdafitinib Erdafitinib The metabolism of Erdafitinib can be increased when combined with Budesonide.
Esomeprazole Injection Esomeprazole Injection Esomeprazole can cause a decrease in the absorption of Budesonide resulting in a reduced serum concentration and potentially a decrease in efficacy.
Risankizumab-rzaa Injection Risankizumab-rzaa Injection The risk or severity of adverse effects can be increased when Budesonide is combined with Risankizumab.
Alpelisib Alpelisib The metabolism of Alpelisib can be increased when combined with Budesonide.
Cladribine Cladribine The risk or severity of adverse effects can be increased when Cladribine is combined with Budesonide.
Solriamfetol Solriamfetol Budesonide may decrease the excretion rate of Solriamfetol which could result in a higher serum level.
Entrectinib Entrectinib The metabolism of Entrectinib can be increased when combined with Budesonide.
Pexidartinib Pexidartinib The metabolism of Pexidartinib can be increased when combined with Budesonide.
Istradefylline Istradefylline The metabolism of Istradefylline can be increased when combined with Budesonide.
Pitolisant Pitolisant The serum concentration of Budesonide can be decreased when it is combined with Pitolisant.
Lefamulin Lefamulin The metabolism of Lefamulin can be increased when combined with Budesonide.
Phenytoin Injection Phenytoin Injection The serum concentration of Phenytoin can be decreased when it is combined with Budesonide.
Fosphenytoin Injection Fosphenytoin Injection The serum concentration of Fosphenytoin can be decreased when it is combined with Budesonide.
Zanubrutinib Zanubrutinib The metabolism of Zanubrutinib can be increased when combined with Budesonide.
Lumateperone Lumateperone The serum concentration of Lumateperone can be decreased when it is combined with Budesonide.
Tazemetostat Tazemetostat The metabolism of Tazemetostat can be increased when combined with Budesonide.
Cenobamate Cenobamate The serum concentration of Budesonide can be decreased when it is combined with Cenobamate.
Ozanimod Ozanimod The risk or severity of adverse effects can be increased when Budesonide is combined with Ozanimod.
Selumetinib Selumetinib The metabolism of Selumetinib can be increased when combined with Budesonide.
Rimegepant Rimegepant The metabolism of Rimegepant can be increased when combined with Budesonide.
Tucatinib Tucatinib The metabolism of Tucatinib can be decreased when combined with Budesonide.
Selpercatinib Selpercatinib The serum concentration of Selpercatinib can be decreased when it is combined with Budesonide.
Capmatinib Capmatinib The serum concentration of Capmatinib can be decreased when it is combined with Budesonide.
Lemborexant Lemborexant The serum concentration of Lemborexant can be decreased when it is combined with Budesonide.
Belantamab Mafodotin-blmf Injection Belantamab Mafodotin-blmf Injection Budesonide may decrease the excretion rate of Belantamab mafodotin which could result in a higher serum level.
Pralsetinib Pralsetinib Pralsetinib may decrease the excretion rate of Budesonide which could result in a higher serum level.
Satralizumab-mwge Injection Satralizumab-mwge Injection The serum concentration of Budesonide can be decreased when it is combined with Satralizumab.
Progestin-Only (drospirenone) Oral Contraceptives Progestin-Only (drospirenone) Oral Contraceptives The serum concentration of Budesonide can be increased when it is combined with Drospirenone.
Viloxazine Viloxazine Budesonide may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Tobramycin Injection Tobramycin Injection Tobramycin may decrease the excretion rate of Budesonide which could result in a higher serum level.
Theophylline Theophylline The metabolism of Theophylline can be increased when combined with Budesonide.
Fenoprofen Fenoprofen The risk or severity of gastrointestinal irritation can be increased when Fenoprofen is combined with Budesonide.
Indomethacin Indomethacin The risk or severity of gastrointestinal irritation can be increased when Indomethacin is combined with Budesonide.
Mefenamic Acid Mefenamic Acid The risk or severity of gastrointestinal irritation can be increased when Mefenamic acid is combined with Budesonide.
Naproxen Naproxen The risk or severity of gastrointestinal irritation can be increased when Naproxen is combined with Budesonide.
Tolmetin Tolmetin The risk or severity of gastrointestinal irritation can be increased when Tolmetin is combined with Budesonide.
Sulindac Sulindac The risk or severity of gastrointestinal irritation can be increased when Sulindac is combined with Budesonide.
Trazodone Trazodone The metabolism of Trazodone can be increased when combined with Budesonide.
Isotretinoin Isotretinoin Isotretinoin may decrease the excretion rate of Budesonide which could result in a higher serum level.
Sucralfate Sucralfate Sucralfate may decrease the excretion rate of Budesonide which could result in a higher serum level.
Sodium Bicarbonate Sodium Bicarbonate The bioavailability of Budesonide can be decreased when combined with Sodium bicarbonate.
Hydroxyurea Hydroxyurea The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Budesonide.
Floxuridine Floxuridine The risk or severity of adverse effects can be increased when Floxuridine is combined with Budesonide.
Phenobarbital Phenobarbital Phenobarbital may increase the excretion rate of Budesonide which could result in a lower serum level and potentially a reduction in efficacy.
Metaxalone Metaxalone Metaxalone may decrease the excretion rate of Budesonide which could result in a higher serum level.
Methotrexate Injection Methotrexate Injection The metabolism of Budesonide can be increased when combined with Methotrexate.
Chlorpromazine Chlorpromazine The therapeutic efficacy of Chlorpromazine can be decreased when used in combination with Budesonide.
Diazepam Diazepam The metabolism of Diazepam can be increased when combined with Budesonide.
Oxazepam Oxazepam Oxazepam may decrease the excretion rate of Budesonide which could result in a higher serum level.
Flurazepam Flurazepam Flurazepam may decrease the excretion rate of Budesonide which could result in a higher serum level.
Clorazepate Clorazepate Clorazepic acid may decrease the excretion rate of Budesonide which could result in a higher serum level.
Lorazepam Lorazepam The metabolism of Lorazepam can be increased when combined with Budesonide.
Carmustine Carmustine The risk or severity of adverse effects can be increased when Carmustine is combined with Budesonide.
Amantadine Amantadine Amantadine may decrease the excretion rate of Budesonide which could result in a higher serum level.
Codeine Codeine Codeine may decrease the excretion rate of Budesonide which could result in a higher serum level.
Bromocriptine Bromocriptine The risk or severity of hyperglycemia can be increased when Budesonide is combined with Bromocriptine.
Metaproterenol Metaproterenol The risk or severity of hypokalemia can be increased when Budesonide is combined with Orciprenaline.
Phenelzine Phenelzine Phenelzine may decrease the excretion rate of Budesonide which could result in a higher serum level.
Procarbazine Procarbazine The risk or severity of adverse effects can be increased when Procarbazine is combined with Budesonide.
Tetracycline Tetracycline Tetracycline may decrease the excretion rate of Budesonide which could result in a higher serum level.
Thioguanine Thioguanine The risk or severity of adverse effects can be increased when Tioguanine is combined with Budesonide.
Prochlorperazine Prochlorperazine The metabolism of Prochlorperazine can be increased when combined with Budesonide.
Bleomycin Bleomycin The risk or severity of adverse effects can be increased when Bleomycin is combined with Budesonide.
Dapsone Dapsone The metabolism of Dapsone can be increased when combined with Budesonide.
Sulfadiazine Sulfadiazine The risk or severity of hyperglycemia can be increased when Budesonide is combined with Sulfadiazine.
Oxycodone Oxycodone The metabolism of Oxycodone can be increased when combined with Budesonide.
Methadone Methadone The metabolism of Methadone can be increased when combined with Budesonide.
Oxybutynin Oxybutynin The metabolism of Oxybutynin can be increased when combined with Budesonide.
Benztropine Benztropine Benzatropine may decrease the excretion rate of Budesonide which could result in a higher serum level.
Maprotiline Maprotiline Maprotiline may decrease the excretion rate of Budesonide which could result in a higher serum level.
Ibuprofen Ibuprofen The risk or severity of gastrointestinal irritation can be increased when Budesonide is combined with Ibuprofen.
Azathioprine Azathioprine The risk or severity of adverse effects can be increased when Azathioprine is combined with Budesonide.
Phentermine Phentermine The metabolism of Phentermine can be increased when combined with Budesonide.
Methylphenidate Methylphenidate Methylphenidate may decrease the excretion rate of Budesonide which could result in a higher serum level.
Sulfasalazine Sulfasalazine The risk or severity of gastrointestinal irritation can be increased when Sulfasalazine is combined with Budesonide.
Hydrocortisone Hydrocortisone The metabolism of Hydrocortisone can be increased when combined with Budesonide.
Lomustine Lomustine The risk or severity of adverse effects can be increased when Lomustine is combined with Budesonide.
Doxorubicin Doxorubicin The metabolism of Budesonide can be increased when combined with Doxorubicin.
Cytarabine Cytarabine The risk or severity of adverse effects can be increased when Cytarabine is combined with Budesonide.
Mechlorethamine Mechlorethamine The therapeutic efficacy of Budesonide can be decreased when used in combination with Mechlorethamine.
Dactinomycin Dactinomycin The risk or severity of adverse effects can be increased when Dactinomycin is combined with Budesonide.
Pyridostigmine Pyridostigmine The therapeutic efficacy of Pyridostigmine can be decreased when used in combination with Budesonide.
Phenazopyridine Phenazopyridine Phenazopyridine may decrease the excretion rate of Budesonide which could result in a higher serum level.
Carbamazepine Carbamazepine The metabolism of Carbamazepine can be increased when combined with Budesonide.
Methyldopa Methyldopa Methyldopa may decrease the excretion rate of Budesonide which could result in a higher serum level.
Clonidine Clonidine The metabolism of Clonidine can be increased when combined with Budesonide.
Hydralazine Hydralazine Budesonide may decrease the excretion rate of Hydralazine which could result in a higher serum level.
Cimetidine Cimetidine Cimetidine can cause a decrease in the absorption of Budesonide resulting in a reduced serum concentration and potentially a decrease in efficacy.
Gentamicin Injection Gentamicin Injection Gentamicin may decrease the excretion rate of Budesonide which could result in a higher serum level.
Warfarin Warfarin The metabolism of Warfarin can be increased when combined with Budesonide.
Clonazepam Clonazepam The metabolism of Clonazepam can be increased when combined with Budesonide.
Loperamide Loperamide The metabolism of Budesonide can be decreased when combined with Loperamide.
Promethazine Promethazine Promethazine can cause a decrease in the absorption of Budesonide resulting in a reduced serum concentration and potentially a decrease in efficacy.
Meclofenamate Meclofenamate The risk or severity of gastrointestinal irritation can be increased when Meclofenamic acid is combined with Budesonide.
Daunorubicin Daunorubicin The risk or severity of adverse effects can be increased when Daunorubicin is combined with Budesonide.
Nitrofurantoin Nitrofurantoin Nitrofurantoin may decrease the excretion rate of Budesonide which could result in a higher serum level.
Digoxin Digoxin The risk or severity of adverse effects can be increased when Budesonide is combined with Digoxin.
Loxapine Loxapine The therapeutic efficacy of Budesonide can be decreased when used in combination with Loxapine.
Chloroquine Chloroquine The metabolism of Chloroquine can be increased when combined with Budesonide.
Quinine Quinine The risk or severity of hyperglycemia can be increased when Quinine is combined with Budesonide.
Calcitriol Calcitriol The therapeutic efficacy of Budesonide can be decreased when used in combination with Calcitriol.
Triamterene Triamterene Triamterene may decrease the excretion rate of Budesonide which could result in a higher serum level.
Sulfinpyrazone Sulfinpyrazone Sulfinpyrazone may decrease the excretion rate of Budesonide which could result in a higher serum level.
Chlorothiazide Chlorothiazide The risk or severity of electrolyte imbalance can be increased when Budesonide is combined with Chlorothiazide.
Chlorthalidone Chlorthalidone Budesonide may increase the hypokalemic activities of Chlorthalidone.
Metolazone Metolazone Budesonide may increase the hypokalemic activities of Metolazone.
Isosorbide Isosorbide The serum concentration of Isosorbide can be increased when it is combined with Budesonide.
Clindamycin Injection Clindamycin Injection The metabolism of Clindamycin can be increased when combined with Budesonide.
Secobarbital Secobarbital Secobarbital may decrease the excretion rate of Budesonide which could result in a higher serum level.
Desipramine Desipramine Desipramine may decrease the excretion rate of Budesonide which could result in a higher serum level.
Amitriptyline Amitriptyline The metabolism of Amitriptyline can be increased when combined with Budesonide.
Imipramine Imipramine Imipramine may decrease the excretion rate of Budesonide which could result in a higher serum level.
Probenecid Probenecid Probenecid may decrease the excretion rate of Budesonide which could result in a higher serum level.
Quinidine Quinidine The metabolism of Budesonide can be increased when combined with Quinidine.
Procainamide Procainamide The therapeutic efficacy of Procainamide can be decreased when used in combination with Budesonide.
Isoniazid Isoniazid The serum concentration of Isoniazid can be decreased when it is combined with Budesonide.
Pyrazinamide Pyrazinamide Pyrazinamide may decrease the excretion rate of Budesonide which could result in a higher serum level.
Rifampin Rifampin Rifampicin may decrease the excretion rate of Budesonide which could result in a higher serum level.
Disopyramide Disopyramide The risk or severity of hyperglycemia can be increased when Budesonide is combined with Disopyramide.
Tamoxifen Tamoxifen The metabolism of Tamoxifen can be increased when combined with Budesonide.
Mitomycin Mitomycin The risk or severity of adverse effects can be increased when Mitomycin is combined with Budesonide.
Butabarbital Butabarbital Butabarbital may decrease the excretion rate of Budesonide which could result in a higher serum level.
Liothyronine Liothyronine Liothyronine may decrease the excretion rate of Budesonide which could result in a higher serum level.
Methimazole Methimazole The metabolism of Budesonide can be decreased when combined with Methimazole.
Propylthiouracil Propylthiouracil The risk or severity of adverse effects can be increased when Propylthiouracil is combined with Budesonide.
Chlorpropamide Chlorpropamide The risk or severity of hyperglycemia can be increased when Chlorpropamide is combined with Budesonide.
Tolbutamide Tolbutamide The risk or severity of hyperglycemia can be increased when Tolbutamide is combined with Budesonide.
Tolazamide Tolazamide The risk or severity of hyperglycemia can be increased when Tolazamide is combined with Budesonide.
Dextromethorphan Dextromethorphan The metabolism of Dextromethorphan can be increased when combined with Budesonide.
Baclofen Baclofen Baclofen may decrease the excretion rate of Budesonide which could result in a higher serum level.
Chlorpheniramine Chlorpheniramine The metabolism of Chlorpheniramine can be increased when combined with Budesonide.
Ethambutol Ethambutol Ethambutol may decrease the excretion rate of Budesonide which could result in a higher serum level.
Methyclothiazide Methyclothiazide The risk or severity of electrolyte imbalance can be increased when Budesonide is combined with Methyclothiazide.
Hydrochlorothiazide Hydrochlorothiazide The risk or severity of electrolyte imbalance can be increased when Budesonide is combined with Hydrochlorothiazide.
Chlorzoxazone Chlorzoxazone Chlorzoxazone may decrease the excretion rate of Budesonide which could result in a higher serum level.
Pyridoxine Pyridoxine Pyridoxine may decrease the excretion rate of Budesonide which could result in a higher serum level.
Folic Acid Folic Acid Folic acid may decrease the excretion rate of Budesonide which could result in a higher serum level.
Danazol Danazol The risk or severity of fluid retention can be increased when Danazol is combined with Budesonide.
Disulfiram Disulfiram The metabolism of Disulfiram can be increased when combined with Budesonide.
Propranolol (Cardiovascular) Propranolol (Cardiovascular) The metabolism of Propranolol can be increased when combined with Budesonide.
Nortriptyline Nortriptyline The metabolism of Nortriptyline can be increased when combined with Budesonide.
Spironolactone Spironolactone Spironolactone may increase the excretion rate of Budesonide which could result in a lower serum level and potentially a reduction in efficacy.
Amphotericin B Injection Amphotericin B Injection The risk or severity of hypokalemia can be increased when Budesonide is combined with Amphotericin B.
Mercaptopurine Mercaptopurine The risk or severity of adverse effects can be increased when Mercaptopurine is combined with Budesonide.
Phytonadione Phytonadione Phylloquinone may decrease the excretion rate of Budesonide which could result in a higher serum level.
Amikacin Injection Amikacin Injection Amikacin may decrease the excretion rate of Budesonide which could result in a higher serum level.
Nadolol Nadolol Nadolol may decrease the excretion rate of Budesonide which could result in a higher serum level.
Cholestyramine Resin Cholestyramine Resin Cholestyramine may increase the excretion rate of Budesonide which could result in a lower serum level and potentially a reduction in efficacy.
Allopurinol Allopurinol Allopurinol may decrease the excretion rate of Budesonide which could result in a higher serum level.
Fluoxymesterone Fluoxymesterone The risk or severity of fluid retention can be increased when Budesonide is combined with Fluoxymesterone.
Flavoxate Flavoxate Flavoxate may decrease the excretion rate of Budesonide which could result in a higher serum level.
Fluorouracil Injection Fluorouracil Injection The risk or severity of adverse effects can be increased when Fluorouracil is combined with Budesonide.
Colchicine Colchicine The risk or severity of adverse effects can be increased when Budesonide is combined with Colchicine.
Cefaclor Cefaclor Cefaclor may decrease the excretion rate of Budesonide which could result in a higher serum level.
Cefadroxil Cefadroxil Cefadroxil may decrease the excretion rate of Budesonide which could result in a higher serum level.
Cefazolin Injection Cefazolin Injection Cefazolin may decrease the excretion rate of Budesonide which could result in a higher serum level.
Cephalexin Cephalexin The metabolism of Cephalexin can be increased when combined with Budesonide.
Cefoxitin Injection Cefoxitin Injection Cefoxitin may decrease the excretion rate of Budesonide which could result in a higher serum level.
Dacarbazine Dacarbazine The risk or severity of adverse effects can be increased when Dacarbazine is combined with Budesonide.
Acetazolamide Acetazolamide Acetazolamide may increase the excretion rate of Budesonide which could result in a lower serum level and potentially a reduction in efficacy.
Cefotaxime Injection Cefotaxime Injection Cefotaxime may decrease the excretion rate of Budesonide which could result in a higher serum level.
Calcitonin Salmon Injection Calcitonin Salmon Injection Salmon calcitonin may decrease the excretion rate of Budesonide which could result in a higher serum level.
Bacillus Calmette-Guerin (BCG) Vaccine Bacillus Calmette-Guerin (BCG) Vaccine The therapeutic efficacy of Budesonide can be decreased when used in combination with Bacillus calmette-guerin substrain tice live antigen.
Ketoconazole Ketoconazole The metabolism of Budesonide can be decreased when combined with Ketoconazole.
Pyrantel Pyrantel The risk or severity of myopathy and weakness can be increased when Pyrantel is combined with Budesonide.
Thiotepa Injection Thiotepa Injection The therapeutic efficacy of Thiotepa can be decreased when used in combination with Budesonide.
Vincristine Injection Vincristine Injection The metabolism of Budesonide can be increased when combined with Vincristine.
Dipyridamole Dipyridamole Dipyridamole may decrease the excretion rate of Budesonide which could result in a higher serum level.
Vinblastine Vinblastine The metabolism of Budesonide can be increased when combined with Vinblastine.
Ethacrynic Acid Ethacrynic Acid Etacrynic acid may decrease the excretion rate of Budesonide which could result in a higher serum level.
Colistimethate Injection Colistimethate Injection Colistimethate may decrease the excretion rate of Budesonide which could result in a higher serum level.
Metoprolol Metoprolol The metabolism of Metoprolol can be increased when combined with Budesonide.
Hydroxyzine Hydroxyzine The metabolism of Hydroxyzine can be increased when combined with Budesonide.
Aspirin Aspirin The risk or severity of gastrointestinal irritation can be increased when Acetylsalicylic acid is combined with Budesonide.
Salsalate Salsalate The risk or severity of gastrointestinal irritation can be increased when Salsalate is combined with Budesonide.
Chlorambucil Chlorambucil The risk or severity of adverse effects can be increased when Chlorambucil is combined with Budesonide.
Alprazolam Alprazolam The metabolism of Alprazolam can be increased when combined with Budesonide.
Temazepam Temazepam Temazepam may decrease the excretion rate of Budesonide which could result in a higher serum level.
Triazolam Triazolam The metabolism of Triazolam can be increased when combined with Budesonide.
Dicyclomine Dicyclomine Dicyclomine may decrease the excretion rate of Budesonide which could result in a higher serum level.
Propantheline Propantheline Propantheline may decrease the excretion rate of Budesonide which could result in a higher serum level.
Trimethoprim Trimethoprim Trimethoprim may decrease the excretion rate of Budesonide which could result in a higher serum level.
Diltiazem Diltiazem The metabolism of Diltiazem can be increased when combined with Budesonide.
Nifedipine Nifedipine The metabolism of Nifedipine can be increased when combined with Budesonide.
Timolol Timolol Timolol may decrease the excretion rate of Budesonide which could result in a higher serum level.
Verapamil Verapamil The metabolism of Verapamil can be increased when combined with Budesonide.
Atenolol Atenolol Atenolol may decrease the excretion rate of Budesonide which could result in a higher serum level.
Pindolol Pindolol Pindolol may decrease the excretion rate of Budesonide which could result in a higher serum level.
Cisplatin Injection Cisplatin Injection The therapeutic efficacy of Budesonide can be decreased when used in combination with Cisplatin.
Diflunisal Diflunisal The risk or severity of gastrointestinal irritation can be increased when Diflunisal is combined with Budesonide.
Piroxicam Piroxicam The risk or severity of gastrointestinal irritation can be increased when Piroxicam is combined with Budesonide.
Bumetanide Bumetanide Bumetanide may increase the excretion rate of Budesonide which could result in a lower serum level and potentially a reduction in efficacy.
Streptozocin Streptozocin The risk or severity of adverse effects can be increased when Streptozocin is combined with Budesonide.
Etoposide Etoposide The metabolism of Etoposide can be increased when combined with Budesonide.
Glyburide Glyburide The risk or severity of hyperglycemia can be increased when Glyburide is combined with Budesonide.
Glipizide Glipizide The risk or severity of hyperglycemia can be increased when Glipizide is combined with Budesonide.
Indapamide Indapamide Budesonide may increase the hypokalemic activities of Indapamide.
Amoxicillin Amoxicillin Amoxicillin may decrease the excretion rate of Budesonide which could result in a higher serum level.
Oxacillin Injection Oxacillin Injection Oxacillin may decrease the excretion rate of Budesonide which could result in a higher serum level.
Pentoxifylline Pentoxifylline Pentoxifylline may decrease the excretion rate of Budesonide which could result in a higher serum level.
Pentamidine Injection Pentamidine Injection The risk or severity of hyperglycemia can be increased when Pentamidine is combined with Budesonide.
Ceftriaxone Injection Ceftriaxone Injection Ceftriaxone may decrease the excretion rate of Budesonide which could result in a higher serum level.
Labetalol Labetalol Labetalol may decrease the excretion rate of Budesonide which could result in a higher serum level.
Auranofin Auranofin Auranofin may decrease the excretion rate of Budesonide which could result in a higher serum level.
Leuprolide Injection Leuprolide Injection Leuprolide may decrease the excretion rate of Budesonide which could result in a higher serum level.
Gemfibrozil Gemfibrozil Budesonide may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.
Dipivefrin Ophthalmic Dipivefrin Ophthalmic Adefovir dipivoxil may decrease the excretion rate of Budesonide which could result in a higher serum level.
Ceftazidime Injection Ceftazidime Injection Ceftazidime may decrease the excretion rate of Budesonide which could result in a higher serum level.
Ketoprofen Ketoprofen The risk or severity of gastrointestinal irritation can be increased when Ketoprofen is combined with Budesonide.
Cefotetan Injection Cefotetan Injection Cefotetan may decrease the excretion rate of Budesonide which could result in a higher serum level.
Pimozide Pimozide The metabolism of Pimozide can be increased when combined with Budesonide.
Flurbiprofen Flurbiprofen The risk or severity of gastrointestinal irritation can be increased when Flurbiprofen is combined with Budesonide.
Amiodarone Amiodarone The metabolism of Amiodarone can be increased when combined with Budesonide.
Aztreonam Injection Aztreonam Injection Aztreonam may decrease the excretion rate of Budesonide which could result in a higher serum level.
Buspirone Buspirone The metabolism of Buspirone can be increased when combined with Budesonide.
Lovastatin Lovastatin The metabolism of Lovastatin can be increased when combined with Budesonide.
Ciprofloxacin Ciprofloxacin The risk or severity of tendinopathy can be increased when Ciprofloxacin is combined with Budesonide.
Mesalamine Mesalamine The risk or severity of gastrointestinal irritation can be increased when Mesalazine is combined with Budesonide.
Diclofenac Diclofenac The risk or severity of gastrointestinal irritation can be increased when Budesonide is combined with Diclofenac.
Interferon Alfa-2b Injection Interferon Alfa-2b Injection The risk or severity of adverse effects can be increased when Interferon alfa-2b is combined with Budesonide.
Clozapine Clozapine Clozapine may decrease the excretion rate of Budesonide which could result in a higher serum level.
Estazolam Estazolam Estazolam may decrease the excretion rate of Budesonide which could result in a higher serum level.
Idarubicin Idarubicin The risk or severity of adverse effects can be increased when Idarubicin is combined with Budesonide.
Ofloxacin Ofloxacin The risk or severity of tendinopathy can be increased when Budesonide is combined with Ofloxacin.
Didanosine Didanosine Didanosine may decrease the excretion rate of Budesonide which could result in a higher serum level.
Fludarabine Injection Fludarabine Injection The risk or severity of adverse effects can be increased when Fludarabine is combined with Budesonide.
Pentostatin Injection Pentostatin Injection The risk or severity of adverse effects can be increased when Pentostatin is combined with Budesonide.
Clarithromycin Clarithromycin The metabolism of Clarithromycin can be decreased when combined with Budesonide.
Etodolac Etodolac The risk or severity of gastrointestinal irritation can be increased when Etodolac is combined with Budesonide.
Felodipine Felodipine The metabolism of Felodipine can be increased when combined with Budesonide.
Fosinopril Fosinopril Fosinopril may decrease the excretion rate of Budesonide which could result in a higher serum level.
Nabumetone Nabumetone The risk or severity of gastrointestinal irritation can be increased when Nabumetone is combined with Budesonide.
Pravastatin Pravastatin Pravastatin may decrease the excretion rate of Budesonide which could result in a higher serum level.
Simvastatin Simvastatin The metabolism of Simvastatin can be increased when combined with Budesonide.
Amlodipine Amlodipine The metabolism of Amlodipine can be increased when combined with Budesonide.
Teniposide Injection Teniposide Injection The metabolism of Teniposide can be increased when combined with Budesonide.
Itraconazole Itraconazole The metabolism of Budesonide can be decreased when combined with Itraconazole.
Lisinopril Lisinopril Lisinopril may decrease the excretion rate of Budesonide which could result in a higher serum level.
Oxaprozin Oxaprozin The risk or severity of gastrointestinal irritation can be increased when Oxaprozin is combined with Budesonide.
Bisoprolol Bisoprolol Bisoprolol may decrease the excretion rate of Budesonide which could result in a higher serum level.
Zolpidem Zolpidem The metabolism of Zolpidem can be increased when combined with Budesonide.
Doxazosin Doxazosin The metabolism of Doxazosin can be increased when combined with Budesonide.
Isradipine Isradipine Isradipine may decrease the excretion rate of Budesonide which could result in a higher serum level.
Omeprazole Omeprazole Omeprazole can cause a decrease in the absorption of Budesonide resulting in a reduced serum concentration and potentially a decrease in efficacy.
Cisapride Cisapride The metabolism of Cisapride can be increased when combined with Budesonide.
Fluvastatin Fluvastatin The metabolism of Fluvastatin can be increased when combined with Budesonide.
Venlafaxine Venlafaxine Venlafaxine may decrease the excretion rate of Budesonide which could result in a higher serum level.
Nizatidine Nizatidine Budesonide can cause a decrease in the absorption of Nizatidine resulting in a reduced serum concentration and potentially a decrease in efficacy.
Famciclovir Famciclovir The metabolism of Famciclovir can be increased when combined with Budesonide.
Fluvoxamine Fluvoxamine Fluvoxamine may decrease the excretion rate of Budesonide which could result in a higher serum level.
Nefazodone Nefazodone The metabolism of Budesonide can be decreased when combined with Nefazodone.
Lamotrigine Lamotrigine Lamotrigine may decrease the excretion rate of Budesonide which could result in a higher serum level.
Losartan Losartan Losartan may decrease the excretion rate of Budesonide which could result in a higher serum level.
Valacyclovir Valacyclovir Valaciclovir may decrease the excretion rate of Budesonide which could result in a higher serum level.
Tramadol Tramadol The metabolism of Budesonide can be increased when combined with Tramadol.
Vinorelbine Injection Vinorelbine Injection The metabolism of Budesonide can be increased when combined with Vinorelbine.
Carboplatin Injection Carboplatin Injection The risk or severity of adverse effects can be increased when Carboplatin is combined with Budesonide.
Lansoprazole Lansoprazole Lansoprazole can cause a decrease in the absorption of Budesonide resulting in a reduced serum concentration and potentially a decrease in efficacy.
Ifosfamide Injection Ifosfamide Injection The metabolism of Ifosfamide can be increased when combined with Budesonide.
Pegaspargase Injection Pegaspargase Injection The risk or severity of adverse effects can be increased when Pegaspargase is combined with Budesonide.
Nicardipine Nicardipine Nicardipine may decrease the excretion rate of Budesonide which could result in a higher serum level.
Bupropion Bupropion Bupropion may decrease the excretion rate of Budesonide which could result in a higher serum level.
Ticlopidine Ticlopidine The metabolism of Ticlopidine can be increased when combined with Budesonide.
Saquinavir Saquinavir The metabolism of Saquinavir can be decreased when combined with Budesonide.
Metformin Metformin The risk or severity of hyperglycemia can be increased when Metformin is combined with Budesonide.
Nisoldipine Nisoldipine The metabolism of Nisoldipine can be increased when combined with Budesonide.
Lamivudine Lamivudine Lamivudine may decrease the excretion rate of Budesonide which could result in a higher serum level.
Acarbose Acarbose The risk or severity of hyperglycemia can be increased when Acarbose is combined with Budesonide.
Glimepiride Glimepiride The risk or severity of hyperglycemia can be increased when Glimepiride is combined with Budesonide.
Gemcitabine Injection Gemcitabine Injection The risk or severity of adverse effects can be increased when Gemcitabine is combined with Budesonide.
Indinavir Indinavir The metabolism of Indinavir can be increased when combined with Budesonide.
Ritonavir Ritonavir The serum concentration of Ritonavir can be increased when it is combined with Budesonide.
Docetaxel Injection Docetaxel Injection The metabolism of Docetaxel can be increased when combined with Budesonide.
Cidofovir Injection Cidofovir Injection Cidofovir may decrease the excretion rate of Budesonide which could result in a higher serum level.
Meropenem Injection Meropenem Injection Meropenem may decrease the excretion rate of Budesonide which could result in a higher serum level.
Clomipramine Clomipramine The metabolism of Clomipramine can be increased when combined with Budesonide.
Zafirlukast Zafirlukast The metabolism of Zafirlukast can be increased when combined with Budesonide.
Fosfomycin Fosfomycin Fosfomycin may decrease the excretion rate of Budesonide which could result in a higher serum level.
Topiramate Topiramate Topiramate may decrease the excretion rate of Budesonide which could result in a higher serum level.
Insulin Lispro Injection Insulin Lispro Injection The risk or severity of hyperglycemia can be increased when Budesonide is combined with Insulin lispro.
Pramipexole Pramipexole Pramipexole may decrease the excretion rate of Budesonide which could result in a higher serum level.
Donepezil Donepezil The therapeutic efficacy of Donepezil can be decreased when used in combination with Budesonide.
Nelfinavir Nelfinavir Nelfinavir may decrease the excretion rate of Budesonide which could result in a higher serum level.
Azithromycin Azithromycin The serum concentration of Azithromycin can be increased when it is combined with Budesonide.
Loratadine Loratadine Loratadine may decrease the excretion rate of Budesonide which could result in a higher serum level.
Nilutamide Nilutamide Nilutamide may decrease the excretion rate of Budesonide which could result in a higher serum level.
Flutamide Flutamide The metabolism of Flutamide can be increased when combined with Budesonide.
Bicalutamide Bicalutamide The metabolism of Bicalutamide can be increased when combined with Budesonide.
Tamsulosin Tamsulosin Tamsulosin may decrease the excretion rate of Budesonide which could result in a higher serum level.
Finasteride Finasteride The metabolism of Finasteride can be increased when combined with Budesonide.
Quetiapine Quetiapine The metabolism of Quetiapine can be increased when combined with Budesonide.
Cefepime Injection Cefepime Injection Cefepime may decrease the excretion rate of Budesonide which could result in a higher serum level.
Cefprozil Cefprozil Cefprozil may decrease the excretion rate of Budesonide which could result in a higher serum level.
Cefpodoxime Cefpodoxime Cefpodoxime may decrease the excretion rate of Budesonide which could result in a higher serum level.
Cetirizine Cetirizine Cetirizine may decrease the excretion rate of Budesonide which could result in a higher serum level.
Tolcapone Tolcapone Tolcapone may decrease the excretion rate of Budesonide which could result in a higher serum level.
Capecitabine Capecitabine The risk or severity of adverse effects can be increased when Capecitabine is combined with Budesonide.
Efavirenz Efavirenz The metabolism of Budesonide can be decreased when combined with Efavirenz.
Abacavir Abacavir Abacavir may decrease the excretion rate of Budesonide which could result in a higher serum level.
Sildenafil Sildenafil The metabolism of Sildenafil can be increased when combined with Budesonide.
Pioglitazone Pioglitazone The risk or severity of hyperglycemia can be increased when Pioglitazone is combined with Budesonide.
Trastuzumab Injection Trastuzumab Injection Trastuzumab may increase the neutropenic activities of Budesonide.
Celecoxib Celecoxib The risk or severity of gastrointestinal irritation can be increased when Budesonide is combined with Celecoxib.
Rosiglitazone Rosiglitazone The risk or severity of hyperglycemia can be increased when Budesonide is combined with Rosiglitazone.
Tolterodine Tolterodine Tolterodine may decrease the excretion rate of Budesonide which could result in a higher serum level.
Thalidomide Thalidomide The risk or severity of adverse effects can be increased when Thalidomide is combined with Budesonide.
Oseltamivir Oseltamivir Oseltamivir may decrease the excretion rate of Budesonide which could result in a higher serum level.
Aluminum Hydroxide Aluminum Hydroxide The bioavailability of Budesonide can be decreased when combined with Aluminum hydroxide.
Balsalazide Balsalazide The risk or severity of gastrointestinal irritation can be increased when Balsalazide is combined with Budesonide.
Nateglinide Nateglinide The risk or severity of hyperglycemia can be increased when Budesonide is combined with Nateglinide.
Galantamine Galantamine The therapeutic efficacy of Galantamine can be decreased when used in combination with Budesonide.
Rabeprazole Rabeprazole Rabeprazole can cause a decrease in the absorption of Budesonide resulting in a reduced serum concentration and potentially a decrease in efficacy.

Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists